Ophthalmic imaging

British Medical Bulletin

Volumn 111, Issue 1, 2014, Pages 77-88

  Ilginis, Tomas ^a   Clarke, Jonathan ^a   Patel, Praveen J ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Fluorescein angiography; Fundus autofluorescence; Indocyanine green angiography; Ophthalmic imaging; Optical coherence tomography; Scanning laser ophthalmoscope

Indexed keywords

FLUORESCEIN; VASCULOTROPIN INHIBITOR;

AGE RELATED MACULAR DEGENERATION; ANTERIOR EYE CHAMBER; ARTERY OCCLUSION; CLINICAL EXAMINATION; CLINICAL TRIAL (TOPIC); CONFOCAL MICROSCOPY; DATA BASE; DIABETIC MACULAR EDEMA; DIAGNOSTIC PROCEDURE; DIGITAL IMAGING; DISEASE COURSE; EVALUATION STUDY; EYE DISEASE; GLAUCOMA; HUMAN; IMAGE ANALYSIS; INDOCYANINE GREEN ANGIOGRAPHY; MEDICAL PHOTOGRAPHY; NON INVASIVE PROCEDURE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRACTICE GUIDELINE; RETINA BLOOD VESSEL OCCLUSION; RETROLENTAL FIBROPLASIA; REVIEW; SCANNING LASER OPHTHALMOSCOPY; TRAINING; VEIN OCCLUSION; EYE DISEASES; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FLUORESCENCE IMAGING; PROCEDURES; TRENDS;

EYE DISEASES; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; OPHTHALMOSCOPY; OPTICAL IMAGING; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84907997728     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldu022     Document Type: Review

References (47)

1. Webb RH, Hughes GW. Scanning laser ophthalmoscope. IEEE Trans Biomed Eng 1981;28:488-92.
2. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-81.
3. Weaver DT, Murdock TJ. Telemedicine detection of type 1 ROP in a distant neonatal intensive care unit. J Am Assoc Pediatr Ophthalmol Strabismus 2012;16:229-33.
4. Hungi B, Vinekar A, Datti N, et al. Retinopathy of prematurity in a rural neonatal intensive care unit in South India-a prospective study. Indian J Pediatr 2012;79: 911-5.
5. Baskaran M, Perera SA, Nongpiur ME, et al. Angle assessment by EyeCam, goniophotography, and gonioscopy. J Glaucoma 2012;21:493-7.
6. Vessani RM, Moritz R, Batis L, et al. Comparison of quantitative imaging devices and subjective optic nerve head assessment by general ophthalmologists to differentiate normal from glaucomatous eyes. J Glaucoma 2009;18:253-61.
7. Xu G, Weinreb RN, Leung CKS. Retinal nerve fiber layer progression in glaucoma. Ophthalmology 2013;120: 2493-500.
8. Potsaid B, Baumann B, Huang D, et al. Ultrahigh speed 1050 nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second. Opt Express 2010;18:20029-48.
9. Huang J, Ding X, Savini G, et al. A comparison between Scheimpflug imaging and optical coherence tomography in measuring corneal thickness. Ophthalmology 2013; 120:1951-8.
10. Bruce A, Pacey IE, Dharni P, et al. Repeatability and reproducibility of macular thickness measurements using Fourier domain optical coherence tomography. Open Ophthalmol J 2009;3:10-4.
11. Lammer J, Scholda C, Prünte C, et al. Retinal thickness and volume measurements in diabetic macular edema: a comparison of four optical coherence tomography systems. Retina 2011;31:48-55.
12. Töteberg-Harms M, Sturm V, Knecht PB, et al. Repeatability of nerve fiber layer thickness measurements in patients with glaucoma and without glaucoma using spectral-domain and time-domain OCT. Graefes Arch Clin Exp Ophthalmol 2012;250:279-87.
13. Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996;103:1260-70.
14. Keane PA, Patel PJ, Liakopoulos S, et al. Evaluation of age-related macular degeneration with optical coherence tomography. Surv Ophthalmol 2012;57:389-414.
15. Krebs I, Ansari-Shahrezaei S, Goll A, et al. Activity of neovascular lesions treated with bevacizumab: comparison between optical coherence tomography and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2008;246:811-5.
16. Malamos P, Sacu S, Georgopoulos M, et al. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration. Invest Ophthalmol Vis Sci 2009;50:4926-33.
17. Tufail A, Patel PJ, Egan C, et al. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ 2010; 340:c2459.
18. Martin DF, Maguire MG, Ying G, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011;364:1897-908.
19. Coscas F, Coscas G, Souied E, et al. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2007;144:592-9.
20. Hibbs SP, Smith A, Chow LP, et al. Colour photographs for screening in neovascular age-related macular degeneration: are they necessary? Eye (Lond) 2011;25:918-21.
21. Keane PA, Liakopoulos S, Jivrajka RV, et al. Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:3378-85.
22. Zweifel SA, Spaide RF, Curcio CA, et al. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010;117:303-12.e1.
23. Khanifar AA, Koreishi AF, Izatt JA, et al. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology 2008;115:1883-90.
24. Guigui B, Querques G, Leveziel N, et al. Spectral-domain optical coherence tomography of early onset large colloid drusen. Retina 2013;33:1346-50.
25. Fleckenstein M, Charbel Issa P, Helb H-M, et al. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2008;49: 4137-44.
26. Nunes RP, Gregori G, Yehoshua Z, et al. Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina. Ophthalmic Surg Lasers Imaging Retina 2013; 44:344-59.
27. Browning DJ, Glassman AR, Aiello LP, et al. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology 2008;115: 1366-71, 1371.e1
28. Mackenzie S, Schmermer C, Charnley A, et al. SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme. PLoS One 2011;6: e14811.
29. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999;127:688-93.
30. Kim BY, Smith SD, Kaiser PK. Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol 2006;142:405-12.
31. Koleva-Georgieva DN, Sivkova NP. Types of diabetic macular edema assessed by optical coherence tomography. Folia Med (Plovdiv) 2008;50:30-8.
32. Gaucher D, Tadayoni R, Erginay A, et al. Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema. Am J Ophthalmol 2005;139:807-13.
33. Ko J, Kwon OW, Byeon SH. Optical coherence tomography predicts visual outcome in acute central retinal vein occlusion. Retina 2014;34:1132-41.
34. Haouchine B, Massin P, Tadayoni R, et al. Diagnosis of macular pseudoholes and lamellar macular holes by optical coherence tomography. Am J Ophthalmol 2004;138:732-9.
35. Duker JS, Kaiser PK, Binder S, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 2013;120:2611-9.
36. Jindahra P, Petrie A, Plant GT. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 2009;132:628-34.
37. Mwanza J-C, Budenz DL, Godfrey DG, et al. Diagnostic performance of optical coherence tomography ganglion cell-inner plexiform layer thickness measurements in early glaucoma. Ophthalmology 2014;121:849-54.
38. Jeoung JW, Choi YJ, Park KH, et al. Macular ganglion cell imaging study: glaucoma diagnostic accuracy of spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2013;54:4422-9.
39. Leite MT, Rao HL, Zangwill LM, et al. Comparison of the diagnostic accuracies of the Spectralis, Cirrus, and RTVue optical coherence tomography devices in glaucoma. Ophthalmology 2011;118:1334-9.
40. Wang B, Nevins JE, Nadler Z, et al. In vivo lamina cribrosa micro-architecture in healthy and glaucomatous eyes as assessed by optical coherence tomography. Invest Ophthalmol Vis Sci 2013;54:8270-4.
41. Qiu X, Gong L, Lu Y, et al. The diagnostic significance of Fourier-domain optical coherence tomography in Sjögren syndrome, aqueous tear deficiency and lipid tear deficiency patients. Acta Ophthalmol 2012;90:e359-66.
42. Guthoff RF, Zhivov A, Stachs O. In vivo confocal microscopy, an inner vision of the cornea-a major review. Clin Experiment Ophthalmol 2009;37:100-17.
43. Han S, Sarunic MV, Wu J, et al. Handheld forward-imaging needle endoscope for ophthalmic optical coherence tomography inspection. J Biomed Opt 2008;13:020505.
44. Lu CD, Kraus MF, Potsaid B, et al. Handheld ultrahigh speed swept source optical coherence tomography instrument using a MEMS scanning mirror. Biomed Opt Express 2014;5:293-311.
45. Grulkowski I, Liu JJ, Potsaid B, et al. Retinal, anterior segment and full eye imaging using ultrahigh speed swept source OCT with vertical-cavity surface emitting lasers. Biomed Opt Express 2012;3:2733-51.
46. Schwartz DM, Fingler J, Kim DY, et al. Phase-variance optical coherence tomography: a technique for noninvasive angiography. Ophthalmology 2014;121:180-7.
47. Livingstone I, Bastawrous A, Giardini ME, et al. Peek: portable eye examination kit. The Smartphone ophthalmoscope. ARVO 2014 poster 1612-D0027.